Extensively Drug Resistant Tb (xdr Tb) - Infectious Diseases

Relevant Publications

Polymerase Chain Reaction (PCR) Profiling of Extensively Drug-Resistant (XDR) Pathogenic Bacteria in Pulmonary Tuberculosis Patients.

Issue Release: 2024

Tuberculosis Disease Among Nonimmigrant Visa Holders Reported to US Quarantine Stations, January 2011-June 2016.

Issue Release: 2024

Identification of novel single nucleotide variants in the drug resistance mechanism of Mycobacterium tuberculosis isolates by whole-genome analysis.

Issue Release: 2024

Genomic and spatial analysis reveal the transmission dynamics of tuberculosis in areas with high incidence of Zhejiang, China: A prospective cohort study.

Issue Release: 2024

Treatment of MDR, pre-XDR, XDR and rifampicin-resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment to the 2022 consensus-based guideline: Tuberculosis in adulthood by the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP) dated 19.09.2023.

Issue Release: 2024

Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against .

Issue Release: 2024

Integrative analysis of multimodal patient data identifies personalized predictors of tuberculosis treatment prognosis.

Issue Release: 2024

In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria.

Issue Release: 2024

Closure of TB pulmonary cavern using endobronchial valve placement.

Issue Release: 2024

Diagnostic accuracy of the Xpert MTB/XDR assay for detection of Isoniazid and second-line antituberculosis drugs resistance at central TB reference laboratory in Tanzania.

Issue Release: 2024

Acupuncture as adjunctive treatment for linezolid-induced peripheral neuropathy: a case series report.

Issue Release: 2024

Efflux pump gene single-nucleotide variants associated with resistance in Mycobacterium tuberculosis isolates with discrepant drug genotypes.

Issue Release: 2024

Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India.

Issue Release: 2024

Intracellular peroxynitrite perturbs redox balance, bioenergetics, and Fe-S cluster homeostasis in Mycobacterium tuberculosis.

Issue Release: 2024

Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.

Issue Release: 2024

Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis.

Issue Release: 2024

[Pre-extensively and extensively drug-resistant tuberculosis, in Libreville, Gabon].

Issue Release: 2024

An Overview of the Management of Drug-Resistant Tuberculosis in Six French-Speaking African Countries from 2018 to 2022.

Issue Release: 2024

Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines.

Issue Release: 2024

Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies.

Issue Release: 2024

When is Ultrasound Used?

What is the Global Fund?

What are Commonly Used ACTs?

What Research is Being Conducted on Apicoplasts?

What are the guidelines for food safety?

How Do Retroviruses Infect Cells?

What are Antiparasitics?

What are Sexually Transmitted Infections?

What is Plasmodium falciparum Malaria?

How Can Resistance be Managed?

Extensively Drug Resistant Tb (xdr Tb) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics